Leukotriene Antagonists

"Leukotriene Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level.

Descriptor ID	D020024
MeSH Number(s)	D06.347.565 D27.505.696.399.450.565
Concept/Terms	Leukotriene Antagonists Leukotriene Antagonists Receptor Antagonists, Leukotriene Antagonists, Leukotriene Receptor Leukotriene Receptor Antagonists Antagonists, Leukotriene

Below are MeSH descriptors whose meaning is more general than "Leukotriene Antagonists".

Chemicals and Drugs [D]
Hormones, Hormone Substitutes, and Hormone Antagonists [D06]
Hormone Antagonists [D06.347]
Leukotriene Antagonists [D06.347.565]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Hormones, Hormone Substitutes, and Hormone Antagonists [D27.505.696.399]
Hormone Antagonists [D27.505.696.399.450]
Leukotriene Antagonists [D27.505.696.399.450.565]

Below are MeSH descriptors whose meaning is related to "Leukotriene Antagonists".

Below are MeSH descriptors whose meaning is more specific than "Leukotriene Antagonists".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Leukotriene Antagonists" by people in this website by year, and whether "Leukotriene Antagonists" was a major or minor topic of these publications.

Bar chart showing 20 publications over 14 distinct years, with a maximum of 3 publications in 2001 and 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	1	0	1
1999	1	0	1
2000	1	0	1
2001	3	0	3
2003	1	0	1
2004	1	0	1
2006	1	0	1
2007	1	1	2
2010	0	1	1
2011	0	1	1
2013	0	1	1
2016	3	0	3
2021	1	0	1
2024	1	1	2

Below are the most recent publications written about "Leukotriene Antagonists" by people in Profiles.

Rayner DG, Liu M, Chu AWL, Chu X, Guyatt GH, Oykhman P, Cao DJ, Moellman J, Ben-Shoshan M, Baker DR, Waserman S, Lang D, Sheikh J, Mathur SK, Beck LA, Khan DA, Oliver ET, Asiniwasis RN, Cole EF, Wheeler KE, Runyon L, Chan J, Trayes KP, Eftekhari S, Gardner DD, Winders T, Saini SS, Bernstein JA, Chu DK. Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: Systematic review and meta-analysis of randomized clinical trials. J Allergy Clin Immunol. 2024 Oct; 154(4):996-1007.

View in: PubMed
Garvey E, Naimi B, Duffy A, Kahn C, Farquhar D, Rosen M, Rabinowitz M, Evertz DP, Most J, Toskala E, Nyquist GG. Medication utilization for patients with chronic rhinosinusitis with nasal polyposis and asthma in 12 months pre- and post-dupilumab initiation. Int Forum Allergy Rhinol. 2024 Aug; 14(8):1399-1401.

View in: PubMed
Han B, Zhang YY, Ye ZQ, Xiao Y, Rasouli J, Wu WC, Ye SM, Guo XY, Zhu L, Rostami A, Wang LB, Zhang Y, Li X. Montelukast alleviates inflammation in experimental autoimmune encephalomyelitis by altering Th17 differentiation in a mouse model. Immunology. 2021 06; 163(2):185-200.

View in: PubMed
Fitzpatrick AM, Jackson DJ, Mauger DT, Boehmer SJ, Phipatanakul W, Sheehan WJ, Moy JN, Paul IM, Bacharier LB, Cabana MD, Covar R, Holguin F, Lemanske RF, Martinez FD, Pongracic JA, Beigelman A, Baxi SN, Benson M, Blake K, Chmiel JF, Daines CL, Daines MO, Gaffin JM, Gentile DA, Gower WA, Israel E, Kumar HV, Lang JE, Lazarus SC, Lima JJ, Ly N, Marbin J, Morgan W, Myers RE, Olin JT, Peters SP, Raissy HH, Robison RG, Ross K, Sorkness CA, Thyne SM, Szefler SJ. Individualized therapy for persistent asthma in young children. J Allergy Clin Immunol. 2016 12; 138(6):1608-1618.e12.

View in: PubMed
Bielory BP, Shah SP, O'Brien TP, Perez VL, Bielory L. Emerging therapeutics for ocular surface disease. Curr Opin Allergy Clin Immunol. 2016 10; 16(5):477-86.

View in: PubMed
Lal D, Jategaonkar AA, Borish L, Chambliss LR, Gnagi SH, Hwang PH, Rank MA, Stankiewicz JA, Lund VJ. Management of rhinosinusitis during pregnancy: systematic review and expert panel recommendations. Rhinology. 2016 06; 54(2):99-104.

View in: PubMed
Chang TS, Lemanske RF, Mauger DT, Fitzpatrick AM, Sorkness CA, Szefler SJ, Gangnon RE, Page CD, Jackson DJ. Childhood asthma clusters and response to therapy in clinical trials. J Allergy Clin Immunol. 2014 Feb; 133(2):363-9.

View in: PubMed
Diette GB, Fuhlbrigge AL, Allen-Ramey F, Hopper A, Sajjan SG, Markson LE. Asthma Severity in patients initiating controller monotherapy versus combination therapy. J Asthma. 2011 Apr; 48(3):304-10.

View in: PubMed
Wolfarth B, Wuestenfeld JC, Kindermann W. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes. Endocrinol Metab Clin North Am. 2010 Mar; 39(1):75-87, ix.

View in: PubMed
Tong WG, Ding XZ, Talamonti MS, Bell RH, Adrian TE. Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells. Anticancer Drugs. 2007 Jun; 18(5):535-41.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement